Colgate-Palmolive Company, a prominent consumer goods firm traded under the ticker CL on the New York Stock Exchange, is set to report its earnings for the second quarter before markets open on Friday, January 30. Market participants anticipate earnings per share of 91 cents, consistent with the prior year’s quarter. Revenue is predicted to reach approximately $5.12 billion, showing an increase relative to the $4.94 billion generated during the same period last year, according to data compiled by Benzinga Pro.
Reflecting on previous quarterly performance, Colgate-Palmolive posted its third-quarter adjusted earnings per share of 91 cents on October 31. This figure surpassed analyst consensus estimates that stood at 89 cents. Meanwhile, reported sales of $5.131 billion aligned with expectations, marking a 2% increase in net sales compared with the prior comparable period.
On the trading front, shares of Colgate-Palmolive experienced a modest uptick of 0.3%, closing at $85.24 on Thursday. Investor interest appears steady as the company approaches this significant earnings announcement.
Analyst Ratings and Price Target Adjustments
Leading analysts noted for their predictive accuracy have provided updated insights on Colgate-Palmolive’s stock ahead of the earnings release. These analysts have adjusted their price targets and ratings based on their assessments of the company's recent performance, competitive positioning, and market conditions.
- JP Morgan’s Andrea Teixeira has reaffirmed an Overweight rating on Colgate-Palmolive, raising the price target from $88 to $93 as of January 16, 2026. This analyst’s track record stands at 60% accuracy in forecasts, suggesting a moderately strong conviction in the company’s near-term outlook.
- UBS analyst Peter Grom continues to recommend the stock with a Buy rating, lifting the price target from $90 to $93 on January 14, 2026. Grom also maintains a 60% accuracy rate in his analyses.
- Wells Fargo’s Chris Carey upgraded the rating from Underweight to Equal-Weight, elevating the price target from $77 to $86 on January 13, 2026. Chris Carey’s forecast accuracy is noted at 61%, indicating a slightly higher confidence in the firm's stability within its sector.
- Robert Moskow of TD Cowen sustained a Buy rating but reduced the price target from $90 to $86 on January 8, 2026. Moskow’s estimations have been 65% accurate, the highest among the referenced analysts, reflecting a solid predictive record.
- Michael Lavery at Piper Sandler upgraded Colgate-Palmolive from Neutral to Overweight, increasing the price target from $82 to $88 as of January 7, 2026. Lavery’s accuracy rate is 63%, further illustrating a generally positive sentiment toward the stock.
Market Context
Investors seeking comprehensive evaluation metrics on Colgate-Palmolive can utilize tools such as Benzinga Rankings, which provide insights into momentum, value, quality, and price trends over different time frames. As of the most recent data, CL shares are priced near $84.70, reflecting a relatively stable short-term market perception prior to the earnings call.
The coming earnings announcement will offer vital data on the company’s financial health and operational trajectory amid evolving market conditions, which have been characterized by modest growth in net sales and consistent earnings performance. These factors will be critical inputs for investors evaluating CL stock positioning and risk exposure.
Summary of Key Points
- Colgate-Palmolive is expected to report steady second-quarter EPS of 91 cents, in line with the previous year.
- Revenue forecasts indicate growth to approximately $5.12 billion, up from $4.94 billion year-over-year.
- Recent analyst adjustments show a mixture of upgraded price targets and ratings, signaling cautious optimism.
- The company’s shares have shown slight gains, closing at $85.24 recently.
Risks and Uncertainties
- Variations in sales growth rates could impact overall earnings quality and guidance outlooks.
- Shifts in analyst sentiment, as evidenced by recent rating upgrades and downgrades, introduce forecast variability.
- Market reaction to the earnings report remains uncertain despite stable projections, potentially influencing share price volatility.